Bone Biologics BBLG
NASDAQ BBLG
$0.40 -0.02 (-4.48%)
As of: Oct 22, 2026 · 11:33 AM EDT

Bone Biologics (BBLG) EBT Margin (2023 - 2024)

Updated

Bone Biologics (BBLG) recorded EBT Margin of -2.42% in FY2016.

Analysis

Bone Biologics (BBLG) EBT Margin (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Thermo Fisher Scientific 254.31 Bn 233.34 Bn 4.88 Bn 16.04%
2 Abbott Laboratories 176.98 Bn 147.41 Bn 7.27 Bn 12.10%
3 Danaher 164.79 Bn 148.60 Bn 3.61 Bn 17.21%
4 Intuitive Surgical 155.89 Bn 135.31 Bn 1.96 Bn 36.46%
5 Medtronic 122.92 Bn 88.18 Bn 6.34 Bn 18.13%
6 Stryker 118.26 Bn 104.38 Bn 4.50 Bn 23.74%
7 Boston Scientific 67.03 Bn 61.80 Bn 3.85 Bn 19.48%
8 Becton Dickinson 54.67 Bn 51.82 Bn 2.32 Bn 11.12%
9 Edwards Lifesciences 51.63 Bn 35.63 Bn 1.35 Bn 29.86%
10 Bone Biologics 720,858.10 -21.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -354,227.84%
Dec 31, 2023 -332,280.52%
Sep 30, 2023 -388,125.75%
Jun 30, 2023 -710,149.53%
Mar 31, 2023 -566,103.78%
API Access

Bone Biologics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=BBLG&period=max&api_key=YOUR_API_KEY